Achiwawanich, S.; Khunnawutmanotham, N.; Techasakul, S.; Chaichit, N.; Siripaisarnpipata, S. 1-(2-Bromobenzoyl)-6,7-(methylenedioxy) Isoquinoline. Acta Cryst. 2011, E67, o112.

The Minderoo-Monaco Commission on Plastics and Human Health Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, Charles D, Chiles TC, Donohue MJ, Enck J, Fenichel P, Fleming LE, Ferrier-Pages C, Fordham R, Gozt A, Griffin C, Hahn ME, Haryanto B, Hixson R, Ianelli H, James BD, Kumar P, Laborde A, Law KL, Martin K, Mu J, Mulders Y, Mustapha A, Niu J, Pahl S, Park Y, Pedrotti M-L, Pitt JA, Ruchirawat M, Seewoo BJ, Spring M, Stegeman JJ, Suk W, Symeonides C, Takada H, Thompson RC, Vicini A, Wang Z, Whitman E, Wirth D, Wolff M, Yousuf AK, Dunlop S Ann Glob Health. 2023;89(1):23.

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*. J Mol Graph Model. 2020 Sep;99:107639.